Australia markets open in 1 hour 21 minutes
  • ALL ORDS

    6,953.40
    +59.80 (+0.87%)
     
  • AUD/USD

    0.6908
    -0.0017 (-0.25%)
     
  • ASX 200

    6,763.60
    +57.60 (+0.86%)
     
  • OIL

    111.92
    +0.16 (+0.14%)
     
  • GOLD

    1,821.00
    -0.20 (-0.01%)
     
  • BTC-AUD

    29,466.27
    -871.41 (-2.87%)
     
  • CMC Crypto 200

    441.05
    -9.01 (-2.00%)
     

Monkeypox cases drove up stock prices for these companies on Monday

·4-min read
Monkeypox cases drove up stock prices for these companies on Monday
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Growing concern about the emergence of monkeypox in Europe and the U.S. has sent shares soaring for several vaccine and drug companies. At least three cases have been confirmed in the U.S. over the past year, including one in an adult male who recently traveled from Canada to Massachusetts. Several companies that developed smallpox vaccines or therapeutics have seen their shares prices jump, and some of those drug makers may be familiar to investors who paid close attention to stocks that got a boost in early 2020 after China first disclosed the outbreak of the new coronavirus that was eventually identified as SARS-CoV-2.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting